Transgenic Pigs with Red-Shifted Channelrhodopsin-Citrine Fusion Proteins
Project Number1OT2OD026582-01
Contact PI/Project LeaderREZNIKOV, LEAH R
Awardee OrganizationUNIVERSITY OF FLORIDA
Description
Abstract Text
PROJECT SUMMARY
Large animals are increasingly utilized in biomedical research and offer an advantage in that their
anatomy and physiology closely parallel humans. Yet despite these advantages, rodent models
dominate many areas of research, including neuroscience. This might be due in part to the greater
number of technologies available to rodent researchers. In the current application, the investigator
proposes to create a new technology to facilitate large animal researchers and bridge this gap.
Specifically, she proposes to create transgenic pigs with red-shifted channelrhodopsin-citrine fusion
proteins or green fluorescent protein/calmodulin protein sensors expressed in neurons. This will allow
for simultaneous visualization of neurons (and their innervation), and the ability to precisely control or
monitor neural activity. An important advantage of the red-shifted channelrhodopsin variant is that it
can be activated by near far red light (~630 nm), thus decreasing phototoxic events and opening the
door to less-invasive methods of neural activation (i.e. through the skin). Moreover, the fusion of the
green fluorescent protein derivative, citrine, will allow for identification of specific neural elements
expressing channelrhodpsin, as well as enable visualization of organ innervation. To create the
transgenic pigs, the investigator proposes to target porcine fetal fibroblasts using piggyBac
transposon technology. The piggyBac transposon system allows for “cut and paste” integration of the
targeting construct into the porcine genome. An advantage of this approach is that it promotes stable
transgene expression. Transgenic pigs will be derived from the targeted fetal fibroblasts at the
University of Missouri where Dr. Randall Prather and his team will perform somatic cell nuclear
transfer. Embryos containing the targeted nuclear material will be transferred to a surrogate gilt and
allowed to develop until term. Transgenic pigs will then be studied and characterized in the
investigator's lab at the University of Florida. The proposed work is completely aligned with the
priorities of SPARC and will facilitate the imaging and targeting of peripheral nerves with end organs
in a large animal model. Moreover, its utility is not limited to peripheral nervous system researchers,
as central nervous system neurons will also express channelrhodopsin-citrine fusion proteins or green
fluorescent protein/calmodulin protein sensors. Thus, the work proposed in this application has the
potential to greatly accelerate the neuroscience field and propel the bench-to-bedside process.
Public Health Relevance Statement
NARRATIVE
Large animals are increasingly utilized in biomedical research yet lag in the tools and technologies
available to address important scientific questions. In the current proposal, transgenic pigs that allow
for precise control and monitoring of neural activity are developed. The creation of these pigs will
bridge an important gap in the field of neuroscience and facilitate the translation of basic science
research into therapeutic interventions.
!
NIH Spending Category
BioengineeringNeurosciences
Project Terms
AddressAnatomyAnimal ModelAnimalsAreaBackBasic ScienceBenchmarkingBiomedical ResearchCalmodulinCellsChimeric ProteinsCholine O-AcetyltransferaseCommunicable DiseasesComplexDatabasesDevice or Instrument DevelopmentDiseaseDoctor of PhilosophyElementsEmbryoEventFamily suidaeFemaleFertilityFibroblastsFloridaGeneticGenomeGoalsGreen Fluorescent ProteinsHousingHumanImageImageryLaboratoriesLifeLightMedicineMethodsMissouriModelingMonitorNervous system structureNeuraxisNeuronsNeurosciencesNuclearOrganPaste substancePeripheral NervesPeripheral Nervous SystemPhototoxicityPhysiologyPlayProcessProteinsRecordsResearchResearch PersonnelResourcesRodentRodent ModelRoleSkinSynapsinsSystemTechnologyTherapeuticTherapeutic InterventionTransgenic OrganismsTranslationsTreatment-related toxicityUniversitiesVariantWorkbench to bedsideblastocystcholinergic neuroncostfetalmalenerve supplynew technologypromoterrelating to nervous systemsensorsomatic cell nuclear transfertechnology developmenttooltransgene expression
No Sub Projects information available for 1OT2OD026582-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1OT2OD026582-01
Patents
No Patents information available for 1OT2OD026582-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1OT2OD026582-01
Clinical Studies
No Clinical Studies information available for 1OT2OD026582-01
News and More
Related News Releases
No news release information available for 1OT2OD026582-01
History
No Historical information available for 1OT2OD026582-01
Similar Projects
No Similar Projects information available for 1OT2OD026582-01